Factor VII polypeptides that are modified and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8519103
APP PUB NO 20090291890A1
SERIAL NO

12384915

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Modified factor VII polypeptides and uses thereof are provided. Such modified FVII polypeptides include Factor VIIa and other forms of Factor VII. Among modified FVII polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GC BIOPHARMA CORP107 IHYEON-RO 30BEON-GIL GIHEUNG-GU YONGIN-SI GYEONGGI-DO 16924

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Madison, Edwin L San Francisco, US 54 991
Thanos, Christopher San Francisco, US 46 493

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 27, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00